BeyondSpring Competitors and Similar CompaniesClear all
Omeros's competitors and similar companies include Otonomy.
 Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. |  Otonomy Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear. | |
Founding Date | Founding Date 1994 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ | Locations San Diego, US HQ |
Employees | Employees 1968% decrease | Employees 49 |
Valuation ($) | Valuation ($) 248.6 m | Valuation ($) 5.3 m |
Financial | ||
Net income | Net income ($3.4m) (FY, 2025) | Net income ($51.2m) (FY, 2021) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 3 (FY, 2021) | Phase I Trials Products 1 (FY, 2016) |
Phase II Trials Products | Phase II Trials Products 2 (FY, 2021) | Phase II Trials Products 2 (FY, 2016) |
Phase III Trials Products | Phase III Trials Products 2 (FY, 2021) | Phase III Trials Products 2 (FY, 2016) |
Funding | ||
Total funding raised | Total funding raised $ 354.8m | Total funding raised $ 153.4m |
For sources of this data, please see the company profile
View Company Profiles
Otonomy
HQ
San Diego, US
Employees
49
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
View company